{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:45:59Z","timestamp":1762508759519,"version":"3.41.2"},"reference-count":48,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T00:00:00Z","timestamp":1651622400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Genet."],"abstract":"<jats:p>N6-Methyladenosine-related long noncoding RNAs play an essential role in many cancers\u2019 development. However, the relationship between m6A-related lncRNAs and acute myelogenous leukemia (AML) prognosis remains unclear. We systematically analyzed the association of m6A-related lncRNAs with the prognosis and tumor immune microenvironment (TME) features using the therapeutically applicable research to generate effective treatment (TARGET) database. We screened 315 lncRNAs associated with AML prognosis and identified nine key lncRNAs associated with m6A by the LASSO Cox analysis. A model was established based on these nine lncRNAs and the predictive power was explored in The Cancer Genome Atlas (TCGA) database. The areas under the ROC curve of TARGET and TCGA databases for ROC at 1, 3, and 5\u00a0years are 0.701, 0.704, and 0.696, and 0.587, 0.639, and 0.685, respectively. The nomogram and decision curve analysis (DCA) showed that the risk score was more accurate than other clinical indicators in evaluating patients\u2019 prognoses. The clusters with a better prognosis enrich the AML pathways and immune-related pathways. We also found a close correlation between prognostic m6A-related lncRNAs and tumor immune cell infiltration. LAG3 expression at the immune checkpoint was lower in the worse prognostic cluster. In conclusion, m6A-related lncRNAs partly affected AML prognosis by remodeling the TME and affecting the anticarcinogenic ability of immune checkpoints, especially LAG3 inhibitors. The prognostic model constructed with nine key m6A-related lncRNAs can provide a method to assess the prognosis of AML patients in both adults and children.<\/jats:p>","DOI":"10.3389\/fgene.2022.888173","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T10:53:43Z","timestamp":1651661623000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":8,"title":["Comprehensive Analysis of N6-Methyladenosine-Related Long Noncoding RNA Prognosis of Acute Myeloid Leukemia and Immune Cell Infiltration"],"prefix":"10.3389","volume":"13","author":[{"given":"Guowei","family":"Zheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mengying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyu","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiting","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ani","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huili","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wanli","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junna","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongsheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaocan","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongli","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuezhong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,4]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1007\/s00262-019-02299-8","article-title":"The Effect of Anti-CTLA4 Treatment on Peripheral and Intra-tumoral T Cells in Patients with Hepatocellular Carcinoma","volume":"68","author":"Agdashian","year":"2019","journal-title":"Cancer Immunol. Immunother."},{"key":"B2","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic Pan-Cancer Analysis of Tumour Purity","volume":"6","author":"Aran","year":"2015","journal-title":"Nat. Commun."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1038\/leu.2014.16","article-title":"WTAP Is a Novel Oncogenic Protein in Acute Myeloid Leukemia","volume":"28","author":"Bansal","year":"2014","journal-title":"Leukemia"},{"key":"B4","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1038\/nature24678","article-title":"Promoter-bound METTL3 Maintains Myeloid Leukaemia by m(6)A-Dependent Translation Control","volume":"552","author":"Barbieri","year":"2017","journal-title":"Nature"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1182\/blood-2013-03-491431","article-title":"Axl, a Prognostic and Therapeutic Target in Acute Myeloid Leukemia Mediates Paracrine Crosstalk of Leukemia Cells with Bone Marrow Stroma","volume":"122","author":"Ben-Batalla","year":"2013","journal-title":"Blood"},{"key":"B6","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1016\/j.immuni.2020.10.020","article-title":"Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade","volume":"53","author":"Bonavita","year":"2020","journal-title":"Immunity"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.1182\/blood-2014-02-554204","article-title":"A Distinct Glucose Metabolism Signature of Acute Myeloid Leukemia with Prognostic Value","volume":"124","author":"Chen","year":"2014","journal-title":"Blood"},{"key":"B8","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1186\/s12943-019-1033-z","article-title":"The Role of m6A RNA Methylation in Human Cancer","volume":"18","author":"Chen","year":"2019","journal-title":"Mol. Cancer"},{"key":"B9","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1186\/s12943-020-01207-4","article-title":"Interaction between N(6)-Methyladenosine (m(6)A) Modification and Noncoding RNAs in Cancer","volume":"19","author":"Chen","year":"2020","journal-title":"Mol. Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/cncr.23220","article-title":"Significance of Age in Acute Myeloid Leukemia Patients Younger Than 30 years: a Common Analysis of the Pediatric Trials AML-BFM 93\/98 and the Adult Trials AMLCG 92\/99 and AMLSG HD93\/98A","volume":"112","author":"Creutzig","year":"2008","journal-title":"Cancer"},{"key":"B11","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/s41577-019-0264-y","article-title":"The Importance of Exosomal PDL1 in Tumour Immune Evasion","volume":"20","author":"Daassi","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1038\/s41419-017-0129-x","article-title":"N6-methyladenosine Links RNA Metabolism to Cancer Progression","volume":"9","author":"Dai","year":"2018","journal-title":"Cell Death Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1186\/s40425-019-0611-3","article-title":"Gal9\/Tim-3 Expression Level Is Higher in AML Patients Who Fail Chemotherapy","volume":"7","author":"Dama","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"B14","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1158\/2159-8290.Cd-18-0774","article-title":"Efficacy, Safety, and Biomarkers of Response to Azacitidine and Nivolumab in Relapsed\/Refractory Acute Myeloid Leukemia: A Nonrandomized, Open-Label, Phase II Study","volume":"9","author":"Daver","year":"2019","journal-title":"Cancer Discov."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.gde.2017.10.005","article-title":"Role of N(6)-Methyladenosine Modification in Cancer","volume":"48","author":"Deng","year":"2018","journal-title":"Curr. Opin. Genet. Dev."},{"key":"B16","doi-asserted-by":"publisher","first-page":"4261","DOI":"10.1038\/srep04261","article-title":"CEBPA-dependent HK3 and KLF5 Expression in Primary AML and during AML Differentiation","volume":"4","author":"Federzoni","year":"2014","journal-title":"Sci. Rep."},{"key":"B17","doi-asserted-by":"publisher","first-page":"142","DOI":"10.3389\/fcell.2020.00142","article-title":"LncRNA NR-104098 Inhibits AML Proliferation and Induces Differentiation through Repressing EZH2 Transcription by Interacting with E2F1","volume":"8","author":"Feng","year":"2020","journal-title":"Front. Cel Dev. Biol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v033.i01","article-title":"Regularization Paths for Generalized Linear Models via Coordinate Descent","volume":"33","author":"Friedman","year":"2010","journal-title":"J. Stat. Softw."},{"key":"B19","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/j.0006-341X.2005.030814.x","article-title":"Survival Model Predictive Accuracy and ROC Curves","volume":"61","author":"Heagerty","year":"2005","journal-title":"Biometrics"},{"key":"B20","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12916-021-01925-6","article-title":"Glycolysis-associated lncRNAs Identify a Subgroup of Cancer Patients with Poor Prognoses and a High-Infiltration Immune Microenvironment","volume":"19","author":"Ho","year":"2021","journal-title":"BMC Med."},{"key":"B21","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.canlet.2008.04.017","article-title":"Receptor Tyrosine Kinase AXL Is Induced by Chemotherapy Drugs and Overexpression of AXL Confers Drug Resistance in Acute Myeloid Leukemia","volume":"268","author":"Hong","year":"2008","journal-title":"Cancer Lett."},{"key":"B22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/5550116","article-title":"An Immune Checkpoint-Related Gene Signature for Predicting Survival of Pediatric Acute Myeloid Leukemia","volume":"2021","author":"Jiang","year":"2021","journal-title":"J. Oncol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"637933","DOI":"10.3389\/fimmu.2021.637933","article-title":"Analysis of m6A-Related Signatures in the Tumor Immune Microenvironment and Identification of Clinical Prognostic Regulators in Adrenocortical Carcinoma","volume":"12","author":"Jin","year":"2021","journal-title":"Front. Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.ccell.2016.11.017","article-title":"FTO Plays an Oncogenic Role in Acute Myeloid Leukemia as a N 6 -Methyladenosine RNA Demethylase","volume":"31","author":"Li","year":"2017","journal-title":"Cancer Cell"},{"key":"B25","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1002\/cam4.3303","article-title":"Exosome\u2010transmitted Linc00852 Associated with Receptor Tyrosine Kinase AXL Dysregulates the Proliferation and Invasion of Osteosarcoma","volume":"9","author":"Li","year":"2020","journal-title":"Cancer Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"770451","DOI":"10.3389\/fcell.2021.770451","article-title":"Identification of m6A-Related lncRNAs Associated with Prognoses and Immune Responses in Acute Myeloid Leukemia","volume":"9","author":"Li","year":"2021","journal-title":"Front. Cel Dev. Biol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/s41419-020-02833-y","article-title":"A Novel N6-Methyladenosine (m6A)-dependent Fate Decision for the lncRNA THOR","volume":"11","author":"Liu","year":"2020","journal-title":"Cel Death Dis"},{"key":"B28","doi-asserted-by":"publisher","first-page":"463","DOI":"10.3389\/fped.2019.00463","article-title":"Targeted Therapies for Pediatric AML: Gaps and Perspective","volume":"7","author":"Lonetti","year":"2019","journal-title":"Front. Pediatr."},{"key":"B29","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/ajh.25620","article-title":"Maintenance Therapy in AML: The Past, the Present and the Future","volume":"94","author":"Molica","year":"2019","journal-title":"Am. J. Hematol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1111\/bjh.15818","article-title":"Hypomethylating Agent Alters the Immune Microenvironment in Acute Myeloid Leukaemia (AML) and Enhances the Immunogenicity of a Dendritic Cell\/AML Vaccine","volume":"185","author":"Nahas","year":"2019","journal-title":"Br. J. Haematol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust Enumeration of Cell Subsets from Tissue Expression Profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"key":"B32","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/s40425-019-0667-0","article-title":"Small Molecule Immunomodulation: the Tumor Microenvironment and Overcoming Immune Escape","volume":"7","author":"Osipov","year":"2019","journal-title":"J. Immunother. Cancer"},{"key":"B33","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1111\/imm.12665","article-title":"Functional Exhaustion of CD4+ T Cells Induced by Co-stimulatory Signals from Myeloid Leukaemia Cells","volume":"149","author":"Ozkazanc","year":"2016","journal-title":"Immunology"},{"key":"B34","doi-asserted-by":"publisher","first-page":"e47","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers Differential Expression Analyses for RNA-Sequencing and Microarray Studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"B35","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1158\/0008-5472.CAN-19-1920","article-title":"Reactive Oxygen Species Drive Proliferation in Acute Myeloid Leukemia via the Glycolytic Regulator PFKFB3","volume":"80","author":"Robinson","year":"2020","journal-title":"Cancer Res."},{"key":"B36","doi-asserted-by":"publisher","first-page":"840","DOI":"10.3390\/ijms20040840","article-title":"Targeting Tumor Microenvironment for Cancer Therapy","volume":"20","author":"Roma-Rodrigues","year":"2019","journal-title":"Ijms"},{"key":"B37","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1038\/nri.2017.108","article-title":"The Diverse Functions of the PD1 Inhibitory Pathway","volume":"18","author":"Sharpe","year":"2018","journal-title":"Nat. Rev. Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.ygeno.2010.02.009","article-title":"Identification of Long Stress-Induced Non-coding Transcripts that Have Altered Expression in Cancer","volume":"95","author":"Silva","year":"2010","journal-title":"Genomics"},{"key":"B39","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1186\/s12943-018-0879-9","article-title":"LncRNA ANRIL Regulates AML Development through Modulating the Glucose Metabolism Pathway of AdipoR1\/AMPK\/SIRT1","volume":"17","author":"Sun","year":"2018","journal-title":"Mol. Cancer"},{"key":"B40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nrc.2016.36","article-title":"Mechanism-driven Biomarkers to Guide Immune Checkpoint Blockade in Cancer Therapy","volume":"16","author":"Topalian","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/nm.4416","article-title":"The N6-Methyladenosine (m6A)-Forming Enzyme METTL3 Controls Myeloid Differentiation of normal Hematopoietic and Leukemia Cells","volume":"23","author":"Vu","year":"2017","journal-title":"Nat. Med."},{"key":"B42","doi-asserted-by":"publisher","first-page":"canres.1674.2020","DOI":"10.1158\/0008-5472.CAN-20-1674","article-title":"Enhanced Efficacy of Simultaneous PD-1 and PD-L1 Immune Checkpoint Blockade in High Grade Serous Ovarian Cancer","volume":"81","author":"Wan","year":"2021","journal-title":"Cancer Res."},{"key":"B43","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.stem.2017.11.016","article-title":"METTL14 Inhibits Hematopoietic Stem\/Progenitor Differentiation and Promotes Leukemogenesis via mRNA m6A Modification","volume":"22","author":"Weng","year":"2018","journal-title":"Cell Stem Cell"},{"key":"B44","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","article-title":"ConsensusClusterPlus: a Class Discovery Tool with Confidence Assessments and Item Tracking","volume":"26","author":"Wilkerson","year":"2010","journal-title":"Bioinformatics"},{"key":"B45","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-019-0224-6","article-title":"TIM3 Comes of Age as an Inhibitory Receptor","volume":"20","author":"Wolf","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring Tumour Purity and Stromal and Immune Cell Admixture from Expression Data","volume":"4","author":"Yoshihara","year":"2013","journal-title":"Nat. Commun."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1080\/21655979.2021.1923381","article-title":"Comprehensive Analysis of N6-Methyladenosine -related Long Non-coding RNAs and Immune Cell Infiltration in Hepatocellular Carcinoma","volume":"12","author":"Yu","year":"2021","journal-title":"Bioengineered"},{"key":"B48","doi-asserted-by":"publisher","first-page":"661758","DOI":"10.3389\/fonc.2021.661758","article-title":"Construction of an Immune-Related Six-lncRNA Signature to Predict the Outcomes, Immune Cell Infiltration, and Immunotherapy Response in Patients with Hepatocellular Carcinoma","volume":"11","author":"Zhou","year":"2021","journal-title":"Front. Oncol."}],"container-title":["Frontiers in Genetics"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.888173\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T10:53:48Z","timestamp":1651661628000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fgene.2022.888173\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,4]]},"references-count":48,"alternative-id":["10.3389\/fgene.2022.888173"],"URL":"https:\/\/doi.org\/10.3389\/fgene.2022.888173","relation":{},"ISSN":["1664-8021"],"issn-type":[{"type":"electronic","value":"1664-8021"}],"subject":[],"published":{"date-parts":[[2022,5,4]]},"article-number":"888173"}}